Ameritas Investment Partners’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
Ameritas Investment Partners's ALT Position: Q2 2026 in Review
Ameritas Investment Partners increased its Altimmune (ALT) stake by 69% in Q2 2026, buying an estimated $22K and bringing the position to 18,039 shares worth $54.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2211.
Ameritas Investment Partners first reported a position in ALT in Q1 2017 and has held it in 18 quarters since. The position peaked at $61.5K in Q4 2023. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.
- Ameritas Investment Partners held 18,039 shares of Altimmune worth $54.8K as of Q2 2026.
- Ameritas Investment Partners bought 7,359 Altimmune shares in Q2 2026, an estimated $22K.
- Altimmune made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2211 holding.
- Ameritas Investment Partners first reported a position in Altimmune in Q1 2017 and has held it in 18 quarters since.
- Ameritas Investment Partners's Altimmune position peaked at $61.5K in Q4 2023.
- 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.